8-KRegulation FDExhibits & Filings

ELI LILLY & Co 8-K Report, Regulation FD Disclosure (Jun 30, 2011)

Filed June 30, 2011For Securities:LLY

Summary

Eli Lilly and Company (LLY) filed an 8-K on June 30, 2011, primarily to disclose information presented at an investor analyst conference held on the same date. The key piece of information furnished is a press release, attached as Exhibit 99.1, which would contain the substantive details discussed during the conference. Investors should refer to this press release for specific updates regarding the company's performance, pipeline, or strategic outlook. While the 8-K itself does not provide the content of the press release, its filing signifies that Lilly is providing material information to the investment community. The purpose of such disclosures is typically to update analysts and investors on significant developments, potentially including financial performance, drug development milestones, regulatory updates, or strategic initiatives. Investors are advised to review the referenced press release to understand the context and implications of this regulatory filing.

Key Highlights

  • 1Eli Lilly and Company (LLY) filed a Form 8-K on June 30, 2011.
  • 2The filing is primarily a Regulation FD Disclosure (Item 7.01).
  • 3Lilly held a conference for investment analysts on June 30, 2011.
  • 4A press release issued in connection with the conference is furnished as Exhibit 99.1 to the 8-K.
  • 5The press release contains material information presented to analysts.
  • 6Investors should review Exhibit 99.1 for specific company updates discussed at the conference.
  • 7No other significant corporate events or financial statements were reported in this 8-K.

Frequently Asked Questions

The main purpose of this 8-K filing by Eli Lilly and Company on June 30, 2011, is to disclose information presented at an investor analyst conference held on the same day. It serves as a notification that material information was shared, and a press release containing these details is attached as an exhibit.

The specific details of the information presented at the analyst conference are contained within the press release dated June 30, 2011, which is furnished as Exhibit 99.1 to this Form 8-K filing. Investors should review this press release for substantive updates.

This particular 8-K filing (dated June 30, 2011) does not appear to contain new financial results or updated financial statements within the body of the report itself. Its primary focus is on disclosing information shared at an analyst conference via a press release.

Regulation FD (Fair Disclosure) is an SEC rule designed to prevent selective disclosure of material non-public information by public companies. A Regulation FD Disclosure on an 8-K means the company is publicly disseminating material information that might otherwise have been shared selectively with certain analysts or investors.